Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415684-17-000025
Filing Date
2017-05-12
Accepted
2017-05-12 13:02:11
Documents
77
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mslp2017q110q.htm 10-Q 544520
2 EXHIBIT 31.1 mslp2017q1ex311.htm EX-31.1 10920
3 EXHIBIT 31.2 mslp2017q1ex312.htm EX-31.2 11168
4 EXHIBIT 32.1 mslp2017q1ex321.htm EX-32.1 5223
5 EXHIBIT 32.2 mslp2017q1ex322.htm EX-32.2 5560
12 GRAPHIC g164971g103625g42y81.jpg GRAPHIC 26397
  Complete submission text file 0001415684-17-000025.txt   3875051

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mslp-20170331.xml EX-101.INS 575503
7 XBRL SCHEMA FILE mslp-20170331.xsd EX-101.SCH 59220
8 XBRL CALCULATION FILE mslp-20170331_cal.xml EX-101.CAL 86018
9 XBRL DEFINITION FILE mslp-20170331_def.xml EX-101.DEF 192978
10 XBRL LABEL FILE mslp-20170331_lab.xml EX-101.LAB 379775
11 XBRL PRESENTATION FILE mslp-20170331_pre.xml EX-101.PRE 297692
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 17837556
SIC: 2834 Pharmaceutical Preparations